Fayuvi is authorized for pediatric patients with preserved neurodevelopmental function following a study comparing treated ...

How direct T-cell reprogramming could simplify CAR-T manufacturing, expand patient access, and extend cellular immunotherapy ...

CCRM CEO Michael May on quantum computing, commercialization, and the next era of cell therapy What was your biggest professional highlight of the past 12 months?

Biopharma is rarely short on scientific promise. But in 2026, the questions facing the industry are increasingly practical: How can complex therapies be developed, manufactured, funded, and ...

Electronic lab notebooks (ELNs) were introduced to modernize laboratory work. But new research from Sapio Sciences suggests many scientists now see them as obstacles rather than enablers of discovery.

An integrated framework combining text mining and knowledge graph modeling supports biopharmaceutical process optimization. This content is an AI-generated, fully rewritten summary based on a ...

We celebrate 60 inspiring individuals helping turn pharma’s boldest ideas into reality Cellares Co-Founder and CEO discusses why the future of cell therapy depends on rethinking how therapies are made ...

New Shanghai manufacturing base and innovation center will support CAR-T production and a broader UK-China life sciences collaboration AstraZeneca is the first major global biopharma to establish ...

Discover how the right excipient can support efficient processing, reliable dosing, fast dissolution and a more patient-friendly experience, and learn what galenIQ™ brings to modern sachet development ...

Johnson & Johnson has entered a strategic collaboration with Sail Biomedicines to develop in vivo CAR T-cell therapies for immune-mediated diseases. Unlike conventional ex vivo CAR T-cell therapies, ...

Earlier this year, Lonza entered into a strategic collaboration with Germany-based biotech Ethris to develop room-temperature stable, spray-dried formulations of mRNA-based vaccine candidates designed ...

Professor Sir Jonathan Van-Tam became a familiar public figure in the UK during the COVID-19 pandemic through his role as Deputy Chief Medical Officer for England – a senior government position ...